Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline Everest Group EG Q1 2026 Earnings Strong EPS Beat Amid Resilient Underwriting Results HOOD Q1 2026 Earnings EPS Misses Estimates Amid Revenue Uncertainty Shares Edge Higher LeonaBio Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction SENEA Q1 2026 Earnings Strong EPS of 619 Reported Amid Quiet Market Reaction Acrivon Therapeutics Q1 2026 Earnings Narrower Loss Per Share as Pipeline Progress Continues